Preliminary results from the Phase 2 clinical trials of Universal Flu vaccine M-001 from Israel’s BiondVax have shown the treatment to be effective and safe. Recipients showed an immune response against strains not included in the standard flu vaccine.

http://www.israel21c.org/news/universal-flu-vaccine-testing-progresses/